Table 4. REMODELING CHANGES BY TREATMENT GROUP.

Paired Data (Winsorized for LV ED^*, LV ES^† and WM^‡)

	PCI§		MED‖		p-value (between groups)
	(N = 55)		(N = 57)
	n	Mean±SD	n	Mean±SD
LV ED Volume (ml)
Baseline	53	118.9±44.1	52	132.7±42.7	0.11
1 yr	53	115.2±43.5	52	131.0±42.3	0.06
Change (1yr-Baseline)	53	−3.7±29.4	52	−1.7±23.6	0.70
p-value (within group)		0.36		0.61
LV ES Volume (ml)
Baseline	53	64.3±35.6	52	75.7±36.5	0.11
1 yr	53	59.5±35.3	52	70.1±35.6	0.13
Change (1yr-Baseline)	53	−4.8±22.3	52	−5.6±18.5	0.84
p-value (within group)		0.13		0.03
Ejection Fraction (%)
Baseline	53	48.7±11.0	52	45.2±11.0	0.11
1 yr	53	51.8±13.0	52	49.3±11.8	0.31
Change (1yr-Baseline)	53	3.1±7.0	52	4.1±7.2	0.49
p-value (within group)		0.002		<0.001
Wall Motion Score
Baseline	53	16.8±8.5	53	18.7±7.9	0.26
1 yr	53	11.6±9.7	53	13.6±8.7	0.27
Change (1yr-Baseline)	53	−5.3±7.5	53	−5.1±5.8	0.89
p-value (within group)		<0.001		<0.001

^*LV ED=left ventricular end-diastolic dimension,

^†LV ES =ventricular end-systolic dimension

^‡WM=wall motion,

^§PCI=percutaneous coronary intervention,

^‖MED=medical therapy alone